COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Anat Achiron*, Mark Dolev, Shay Menascu, Daniela Noa Zohar, Sapir Dreyer-Alster, Shmuel Miron, Emanuel Shirbint, David Magalashvili, Shlomo Flechter, Uri Givon, Diana Guber, Yael Stern, Michael Polliack, Rina Falb, Michael Gurevich

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Fingerprint

Dive into the research topics of 'COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021'. Together they form a unique fingerprint.

Medicine & Life Sciences